You are here: Home / OH BRC Newsletters / Issue 14
Issue 14
Welcome to the March 2025 issue of the Oxford Health Biomedical Research Centre (OH BRC) newsletter which summarises all recently published news and updates in one place.
Celebrating International Women’s Day: An interview with OH BRC Director
In recognition of International Women’s Day (8 March), Professor Rachel Upthegrove spoke to us about her distinguished career in psychiatry, what motivates her and what advice she has for women who want to progress in Science Technology Engineering and Maths (STEM) careers.
The National Institute for Health and Care Research (NIHR) Research Delivery Network is hosting a webinar on Tuesday, 18 March, from 7pm to 8pm. The public is invited to ask questions about the latest ADHD research to leading specialists, Senior Medic at Oxford Health Clinical Research Facility (OH CRF) Dr. Edoardo Ostinelli and Professor Samuele Cortese .
Our mid-term review with International Advisory Board a success
Recently, our Mid-Term Review event with International Advisory Board members evaluated progress, identified challenges, celebrated successes, and set priorities for the future.
OH BRC Strategic Partner and Director of Surrey Clinical Research Facility, Dr Hana Hassanin recently shared her thoughts on “The Right Approach to Inclusivity” in an insightful article where she talks about understanding and appreciating differences, thoughtful implementation of inclusivity, the value in diverse perspectives in society and more.
Digital cognitive behavioural therapy (CBT) for insomnia and emotional processing
A recent study, carried out by researchers at the University of Oxford and OH BRC found that CBT for insomnia did not significantly alter emotional processing of facial expressions following treatment in individuals with clinically significant depressive symptoms.
Celebrating the Oxford Brain Health Clinic with its participants
The Oxford Brain Health Clinic (OBHC) recently hosted an event at Cornerstone Arts Centre, Didcot, to update research participants on the impact of their data in dementia prevention and treatment. Supported by the Patient and Public (PPI) Advisory Group, the event welcomed around 40 attendees, including patients and their companions.
UK-French Mental Health Biomarkers Consortium Event
The first meeting of the UK-French Mental Health Biomarkers Consortium took place recently in Oxford. The consortium is an international initiative focused on revolutionising mental health diagnosis and treatment through biomarker identification and validation. It unites experts from the UK and France and aims to harmonise data collection, advance joint projects, and create valid diagnostic categories for effective treatments.
New Alzheimer's Disease study at OH CRF looking for participants
The ReTain study is looking for volunteers aged 55-75 without a memory condition to evaluate the safety and effectiveness of an immunotherapy treatment in slowing the progression of Alzheimer’s Disease.
Researchers find link between proteins in neck lymph nodes and Alzheimer’s disease
Researchers at the University of Oxford’s Department of Psychiatry, supported by o, found Alzheimer’s disease-related proteins in cervical lymph nodes. This suggests brain drainage becomes less effective with age, potentially leading to Alzheimer’s. They are recruiting participants for a larger study called ‘ANIMATE’.
The ASCEND network has been launched to support women and gender non-conforming researchers and staff at the University of Oxford’s Medical Sciences Division and NIHR Oxford BRC in developing as research leaders. The network was introduced at an event on February 11 at the Kennedy Institute for Rheumatology.
